Oregon 97239 < Osaka < Osaka

Facettes : Author.f AffPays.f Mesh.f AffRegion.f AffVille.f AffOrg.f

List of bibliographic references

Number of relevant bibliographic references: 56.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000016 (2020)	Takashi Shimizu ; Akie Kikuchi-Taura ; Soichiro Tsuji [Japon] ; Masato Matsushita [Japon] ; Shiro Ohshima ; Yukihiko Saeki	Up-regulation of CD64 Expression on Monocytes in Patients With Active Adult-Onset Still Disease: A Possible Biomarker of Disease Activity.
000093 (2020)	Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Kei Ikeda [Japon] ; Tomonori Ishii [Japon] ; Kosaku Murakami [Japon] ; Hyota Takamatsu [Japon] ; Yoshiya Tanaka [Japon] ; Takayuki Abe [Japon] ; Tsutomu Takeuchi [Japon]	Response to: 'Some concerns from Turkey' by Bilgin et al.
000182 (2020)	Kosuke Ebina [Japon] ; Toru Hirano [Japon] ; Yuichi Maeda [Japon] ; Wataru Yamamoto [Japon] ; Motomu Hashimoto [Japon] ; Koichi Murata [Japon] ; Tohru Takeuchi [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Akira Onishi [Japon] ; Sadao Jinno [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Keiichi Yamamoto [Japon] ; Atsushi Kumanogoh [Japon] ; Makoto Hirao [Japon]	Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study.
000204 (2020)	Miho Murakami [Japon] ; Takeshi Johkoh [Japon] ; Seiji Hayashi [Japon] ; Shiro Ohshima [Japon] ; Masao Mizuki [Japon] ; Shin-Ichi Nakatsuka [Japon] ; Minako Tomobe ; Kazuyuki Kuroyanagi ; Ayako Nakasone ; Norihiro Nishimoto [Japon]	Clinicopathologic characteristics of 342 patients with multicentric Castleman disease in Japan.
000330 (2019)	H. Shimagami [Japon] ; Y. Katada [Japon]	Successful treatment with tocilizumab for massive ascites due to secondary amyloidosis complicating rheumatoid arthritis: a case report.
000362 (2019)	Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Kei Ikeda [Japon] ; Tomonori Ishii [Japon] ; Kosaku Murakami [Japon] ; Hyota Takamatsu [Japon] ; Yoshiya Tanaka [Japon] ; Takayuki Abe [Japon] ; Tsutomu Takeuchi [Japon]	Response to: 'Tocilizumab in patients with adult-onset Still's disease refractory to glucocorticoid treatment' by Lee.
000365 (2019)	Yoshikazu Nakaoka [Japon]	Response to: 'Aortic ulceration in a tocilizumab-treated patient with Takayasu arteritis' by Liebling et al.
000406 (2019)	Chiharu Iwahashi [Japon] ; Hikari Ono [Japon] ; Mami Haruta [Japon] ; Takamasa Minami [Japon] ; Hisashi Mashimo [Japon] ; Hiroshi Shimojo [Japon] ; Nobuyuki Ohguro [Japon]	New onset or exacerbation of uveitis with infliximab: paradoxical effects?
000456 (2019)	Atsushi Ogata [Japon] ; Yasuhiro Kato [Japon] ; Shinji Higa [Japon] ; Kazuyuki Yoshizaki [Japon]	IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review.
000502 (2019)	Kosuke Ebina [Japon] ; Motomu Hashimoto [Japon] ; Wataru Yamamoto [Japon] ; Toru Hirano [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Akira Onishi [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Keiichi Yamamoto [Japon] ; Yuichi Maeda [Japon] ; Koichi Murata [Japon] ; Sadao Jinno [Japon] ; Tohru Takeuchi [Japon] ; Makoto Hirao [Japon] ; Atsushi Kumanogoh [Japon] ; Hideki Yoshikawa [Japon]	Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis -The ANSWER cohort study.
000503 (2019)	Kosuke Ebina [Japon] ; Motomu Hashimoto [Japon] ; Wataru Yamamoto [Japon] ; Toru Hirano [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Akira Onishi [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Keiichi Yamamoto [Japon] ; Yuichi Maeda [Japon] ; Koichi Murata [Japon] ; Sadao Jinno [Japon] ; Tohru Takeuchi [Japon] ; Makoto Hirao [Japon] ; Atsushi Kumanogoh [Japon] ; Hideki Yoshikawa [Japon]	Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis-the ANSWER cohort study.
000508 (2019)	Tadamitsu Kishimoto [Japon]	Discovery of IL-6 and Development of Anti-IL-6R Antibody.
000614 (2018)	Takashi Shimizu ; Akie Kikuchi-Taura ; Soichiro Tsuji [Japon] ; Masato Matsushita [Japon] ; Shiro Ohshima ; Yukihiko Saeki	Up-regulation of CD64 Expression on Monocytes in Patients With Active Adult-Onset Still Disease: A Possible Biomarker of Disease Activity.
000640 (2018)	Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Kei Ikeda [Japon] ; Tomonoti Ishii [Japon] ; Kosaku Murakami [Japon] ; Hyota Takamatsu [Japon] ; Yoshiya Tanaka [Japon] ; Takayuki Abe [Japon] ; Tsutomu Takeuchi [Japon]	Tocilizumab in patients with adult-onset still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial.
000783 (2018)	Frits Van Rhee [États-Unis] ; Peter Voorhees [États-Unis] ; Angela Dispenzieri [États-Unis] ; Alexander Foss [Norvège] ; Gordan Srkalovic [États-Unis] ; Makoto Ide [Japon] ; Nikhil Munshi [États-Unis] ; Stephen Schey [Royaume-Uni] ; Matthew Streetly [Royaume-Uni] ; Sheila K. Pierson [États-Unis] ; Helen L. Partridge [États-Unis] ; Sudipto Mukherjee [États-Unis] ; Dustin Shilling [États-Unis] ; Katie Stone [États-Unis] ; Amy Greenway [États-Unis] ; Jason Ruth [États-Unis] ; Mary Jo Lechowicz ; Shanmuganathan Chandrakasan [États-Unis] ; Raj Jayanthan [États-Unis] ; Elaine S. Jaffe [États-Unis] ; Heather Leitch [Canada] ; Naveen Pemmaraju [États-Unis] ; Amy Chadburn [États-Unis] ; Megan S. Lim ; Kojo S. Elenitoba-Johnson ; Vera Krymskaya [États-Unis] ; Aaron Goodman [États-Unis] ; Christian Hoffmann [Allemagne] ; Pier Luigi Zinzani [Italie] ; Simone Ferrero [Italie] ; Louis Terriou [France] ; Yasuharu Sato [Japon] ; David Simpson [Nouvelle-Zélande] ; Raymond Wong [Hong Kong] ; Jean-Francois Rossi [France] ; Sunita Nasta [États-Unis] ; Kazuyuki Yoshizaki [Japon] ; Razelle Kurzrock [États-Unis] ; Thomas S. Uldrick [États-Unis] ; Corey Casper [États-Unis] ; Eric Oksenhendler [France] ; David C. Fajgenbaum [États-Unis]	International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.
000830 (2018)	Motomu Hashimoto [Japon] ; Moritoshi Furu [Japon] ; Wararu Yamamoto [Japon] ; Takanori Fujimura [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Akira Ohnishi [Japon] ; Kengo Akashi [Japon] ; Shuzo Yoshida [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Toru Hirano [Japon] ; Kosuke Ebina [Japon] ; Ryuji Uozumi [Japon] ; Hiromu Ito [Japon] ; Masao Tanaka [Japon] ; Koichiro Ohmura [Japon] ; Takao Fujii [Japon] ; Tsuneyo Mimori [Japon]	Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study.
000844 (2018)	Yoshikazu Nakaoka [Japon] ; Mitsuaki Isobe [Japon] ; Syuji Takei [Japon] ; Yoshiya Tanaka [Japon] ; Tomonori Ishii [Japon] ; Shumpei Yokota [Japon] ; Akira Nomura [Japon] ; Seitaro Yoshida [Japon] ; Norihiro Nishimoto [Japon]	Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study).
000861 (2018)	Kosuke Ebina [Japon] ; Motomu Hashimoto [Japon] ; Wataru Yamamoto [Japon] ; Akira Ohnishi [Japon] ; Daijiro Kabata [Japon] ; Toru Hirano [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Shuzo Yoshida [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Kengo Akashi [Japon] ; Takanori Fujimura [Japon] ; Makoto Hirao [Japon] ; Keiichi Yamamoto [Japon] ; Ayumi Shintani [Japon] ; Atsushi Kumanogoh [Japon] ; Hideki Yoshikawa [Japon]	Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study.
000A79 (2017)	Koji Tsuzaki [Japon] ; Takashi Nakamura [Japon] ; Hiroyuki Okumura [Japon] ; Naoko Tachibana [Japon] ; Toshiaki Hamano [Japon]	Rheumatoid Meningitis Occurring during Etanercept Treatment.
000B16 (2017)	Gerd R. Burmester [Allemagne] ; Ernest Choy [Royaume-Uni] ; Alan Kivitz [États-Unis] ; Atsushi Ogata [Japon] ; Min Bao [États-Unis] ; Akira Nomura [Japon] ; Stuart Lacey [Royaume-Uni] ; Jinglan Pei [États-Unis] ; William Reiss [États-Unis] ; Attila Pethoe-Schramm [Suisse] ; Navita L. Mallalieu [États-Unis] ; Thomas Wallace [États-Unis] ; Margaret Michalska [États-Unis] ; Herbert Birnboeck [Suisse] ; Kay Stubenrauch [Allemagne] ; Mark C. Genovese [États-Unis]	Low immunogenicity of tocilizumab in patients with rheumatoid arthritis.
000E31 (2016)	Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Tadamitsu Kishimoto [Japon]	Immunotherapeutic implications of IL-6 blockade for cytokine storm.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/AffRegInc.i -k "Osaka" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/AffRegInc.i  \
                -Sk "Osaka" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    AffRegInc.i
   |clé=    Osaka
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021